Most of these steel producers are supplying liquid oxygen from their manufacturing plants to different states. Mumbai-based JSW Steel, for example, is currently supplying 600 tonne of liquid oxygen for medical use to hospitals in Maharashtra and Karnataka. The company, however, expects this to have no impact on steel production.
“In our production process, we use gaseous oxygen. What we are supplying to hospitals is called liquid medical oxygen (LMO), which is a byproduct for us during the production of oxygen for captive use. Second, total LMO supplied by us uses only a fraction of JSW’s total oxygen manufacturing capacity and metal production at all our plants is on schedule,” said a senior JSW Steel executive told Business Standard.
According to him, the company can supply even more LMO, if required. “In our calculation, we can easily supply up to 900 tonne of liquid oxygen every day, against 600 tonne currently, without affecting metal production at our units,” he said.
The central government has barred the industrial use of oxygen, except for nine sectors, including steel production. The move is likely to hit the production in steel’s downstream industries sectors, such as engineering, metal fabrication, auto component, and consumer durable.
This will likely hit demand for steel in the short term, forcing steelmakers to scale up exports or increase their inventory of finished steel.
“The disruption in the supply of oxygen for industrial use will temporarily impact revenues of small and mid-sized companies into metal fabrication, automotive components, shipbreaking, paper, and engineering,” said Gautam Shahi, director, CRISIL Ratings. He expects the disruption in oxygen supplies for industrial use to last for six-eight weeks, given the current curve of Covid-19 infections.
According to rating agency Crisil, the demand for medical oxygen is estimated to have rocketed fivefold in the second week of April versus pre-pandemic levels, as Covid-19 infections took off.
This stock market is, however, not overly bothered about Covid-19 impact on metal demand in the country and steel stocks continue to outperform the broader market.
The combined market capitalisation of the country's top four primary steel producers — Tata Steel, JSW Steel, SAIL, and JSPL — is up 29 per cent in April, so far, against a 2.3 per cent decline in the benchmark BSE Sensex during the period. The combined market capitalisation of steelmakers has more than doubled (up 131 per cent) since the end of October 2020, against a 22 per cent rally in the Sensex during the period.
All major steel stocks outperformed the broader market on Monday, led by SAIL. The public sector steel major was up 8 per cent, followed by JSW Steel (3.3 per cent).
Most analysts remain bullish on steel companies given strong metal demand from China translating into higher prices for steel. China accounts for nearly 55 per cent of the global steel consumption.
Hot-rolled steel prices in China are up 20 per cent over the past month, pushing up steel prices across the globe, according to the data from Bloomberg.
Analysts say that higher demand from China will more than offset any demand softening in India, while higher landed cost of steel will provide an incentive to domestic steelmakers to take further price hikes.
“Our channel checks indicate steel producers may effect a phased hike of ~4,000 per tonne through May, as the landed price of imports is 10–12 per cent higher than domestic prices. Second, export realisation is at a premium of 5 per cent to prevailing domestic price,” write Amit Dixit and Meera Midha of Edelweiss Securities in their recent report on the steel sector.
Analysts say that higher steel prices are also supported by the recent rise in the price of iron ore and coking coal —two main ingredients for the manufacturing of primary steel. Iron ore prices are up by around 7 per cent over the past month.
Among individual stocks, analysts are most bullish on Tata Steel, SAIL, and JSPL, given their still low valuation, compared to historical averages. JSW Steel, on the other hand, is expected to underperform peers because of its premium valuation.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in